Medical Policies
Preauthorization for acute inpatient care, long term acute care hospital (LTACH), select procedures and select behavioral health services will be conducted using Change Healthcare's InterQual® criteria. InterQual criteria are an industry standard set of objective evidence-based utilization management (UM) criteria for level of care placement and medical necessity determinations, including length of stay. These criteria are specific and comprehensive clinical guidelines developed by a highly trained clinical team who performs unbiased, systematic review and clinical appraisal of the evidence to help ensure the criteria reflect the best available clinical evidence. The criteria are updated frequently to remain current with the latest evidence.
Preauthorization for select substance use disorder services will be performed using the American Society of Addiction Medicine (ASAM) criteria.
ASAM criteria are an industry standard collection of guidelines for level of care placement and medical necessity determinations, including length of stay for substance use disorder services.
Find the medical policy you need in the library below. If medical policy is not located, please refer to the list of specialized services to confirm if medical necessity review is needed.
For specialized services administered by independent companies on behalf of Capital Blue Cross:
- High Tech Radiology including Cardiac Imaging and Radiation Oncology
- Laboratory Services
- Molecular Lab Management Services – Effective January 1, 2026, EviCore’s management of preauthorization for outpatient molecular and genomic tests will be expanded to include Capital Blue Cross Administrative Services Only (ASO) members. (select ASO groups excluded). As of November 1, 2025, EviCore began managing these services for Commercial Fully Insured, CHIP, and Medicare Advantage members.
- Musculoskeletal policies including hip, knee, shoulder and spine related services
- Select Diagnostic and Surgical Cardiology Services
You can also view the out-of-area medical policies.
Specialty Injectables:
Effective January 1, 2026, Prime Medical Pharmacy Solutions1 (Prime MPS) will manage services related to specialty medical injectable drugs, on behalf of Capital.
Specialty injectable drugs may require preauthorization through Prime MPS. Please refer to the single source preauthorization code list. Additionally, some drugs may have a site of service requirement.
To learn more about coverage criteria, including Drug Infusion Site of Service requirements, you may access Prime’s medical drug policies.
1On behalf of Capital Blue Cross, Prime Medical Pharmacy Solutions (Prime MPS), a division of Prime Therapeutics Management LLC an independent company, provides medical specialty drug management services.
Medicare Information:
For additional Medicare coverage and policy information, please review the Medicare Medical Policy page.
Search active and retired medical policies
Policy number |
Category |
Policy title |
Policy type |
|---|---|---|---|
|
MP 1.012 |
Surgery |
Active |
|
|
MP 2.376 |
Medicine |
Active |
|
|
MP 2.087 |
Medicine |
Active |
|
|
MP 2.390 |
Medicine |
Active |
|
|
MP 6.056 |
Durable Medical Equipment |
Adjustable Cranial Orthoses for Positional Plagiocephaly and Craniosynstoses |
Active |
|
MP 3.017 |
Ancillary Services |
Active |
|
|
MP 6.015 |
Ancillary Services |
Active |
|
|
MP 2.001 |
Medicine |
Active |
|
|
MP 9.056 |
Transplant |
Allogeneic HCT for Myelodysplastic Syndromes and Myeloproliferative Neoplasms |
Active |
|
MP 9.055 |
Transplant |
Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias |
Active |
|
MP 1.159 |
Surgery |
Active |
|
|
MP 2.359 |
Medicine |
Active |
|
|
MP 6.062 |
Durable Medical Equipment |
Active |
|
|
MP 2.149 |
Medicine |
Active |
|
|
MP 2.304 |
Medicine |
Active |
|
|
MP 2.317 |
Medicine |
BCR-ABL1 Testing in Chronic Myelogenous Leukemia (CML) and Acute Lymphoblastic Leukemia |
Active |
|
MP 1.157 |
Surgery |
Active |
|
|
MP 1.119 |
Surgery |
Active |
|
|
MP 1.015 |
Surgery |
Active |
|
|
MP 1.142 |
Surgery |
Active |
|
|
MP 1.158 |
Surgery |
Active |
|
|
MP 2.064 |
Medicine |
Active |
|
|
MP 2.190 |
Medicine |
Bioimpedance Devices for Detection and Management of Lymphedema |
Active |
|
MP 1.003 |
Surgery |
Blepharoplasty, Repair of Brow Ptosis and Reconstructive Eyelid Surgery |
Active |
|
MP 2.081 |
Medicine |
Active |
|
|
MP 2.158 |
Medicine |
Active |
|
|
MP 2.051 |
Medicine |
Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting |
Active |
|
MP 2.258 |
Medicine |
Active |
|
|
MP 7.028 |
OBGYN/Reproduction |
Chromosomal Microarray Testing for the Evaluation of Pregnancy Loss |
Active |
|
MP 2.267 |
Medicine |
Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy) |
Active |
|
MP 1.039 |
Surgery |
Closure Devices for Patent Foramen Ovale and Atrial Septal Defects (ASD) |
Active |
|
MP 1.023 |
Surgery |
Active |
|
|
MP 6.013 |
Durable Medical Equipment |
Compression Devices for Treatment of Lymphedema and Peripheral Vascular Disease |
Active |
|
MP 1.106 |
Surgery |
Active |
|
|
MP 5.062 |
Radiology/Imaging |
Active |
|
|
MP 2.093 |
Medicine |
Active |
|
|
MP 6.004 |
Durable Medical Equipment |
Active |
|
|
MP 6.039 |
Durable Medical Equipment |
Active |
|
|
MP 6.040 |
Durable Medical Equipment |
Active |
|
|
MP 2.028 |
Medicine |
Active |
|
|
MP 9.011 |
Transplant |
Corneal Surgery (Formerly Corneal Transplant, Endothelial Keratoplasty, and Keratoprostheses) |
Active |
|
MP 1.004 |
Surgery |
Active |
|
|
MP 2.092 |
Medicine |
Cranial Electrotherapy Stimulation and Auricular Electrostimulation |
Active |
|
MP 1.088 |
Surgery |
Cryoablation of Tumors Located in the Kidney, Lung, Breast, Pancreas, or Bone |
Active |
|
MP 1.121 |
Surgery |
Active |
|
|
MP 2.234 |
Medicine |
Active |
|
|
MP 1.042 |
Surgery |
Active |
|
|
MP 2.381 |
Medicine |
Active |
|
|
MP 1.092 |
Surgery |
Active |
|
|
MP 4.018 |
Other Treatments |
Active |
|
|
MP 4.033 |
Other Treatments |
Active |
|
|
MP 5.048 |
Radiology/Imaging |
Active |
|
|
MP 2.045 |
Medicine |
Active |
|
|
MP 2.050 |
Medicine |
Diagnostic Testing and Risk Assessment for Alzheimer Disease (Biochemical and Genetic) |
Active |
|
MP 2.004 |
Medicine |
Donor Lymphocyte Infusion for Hematologic Malignancies Treated with an Allogeneic HCT |
Active |
|
MP 4.041 |
Other Treatments |
Active |
|
|
MP 6.026 |
Durable Medical Equipment |
Active |
|
|
MP 2.011 |
Medicine |
Active |
|
|
MP 5.051 |
Radiology/Imaging |
Active |
|
|
MP 1.024 |
Surgery |
Electrical Bone Growth Stimulation of the Appendicular Skeleton |
Active |
|
MP 1.150 |
Surgery |
Electrical Stimulation of the Spine as an Adjunct to Spinal Fusion Procedures |
Active |
|
MP 2.096 |
Medicine |
Electromyography (EMG) (Needle and Non-Needle) of the Anal or Urethral Sphincter |
Active |
|
MP 2.063 |
Medicine |
Active |
|
|
MP 7.013 |
OBGYN/Reproduction |
Active |
|
|
MP 1.118 |
Surgery |
Endoscopic Radiofrequency Ablation or Cryoablation for Barrett's Esophagus |
Active |
|
MP 1.090 |
Surgery |
Active |
|
|
MP 1.132 |
Surgery |
Endovascular Stent Grafts for Disorders of the Thoracic Aorta |
Active |
|
MP 2.015 |
Medicine |
Active |
|
|
MP 4.014 |
Other Treatments |
Epidural Steroid Injections for Back Pain and Facet Nerve Blocks |
Active |
|
MP 2.016 |
Medicine |
Active |
|
|
MP 2.367 |
Medicine |
Active |
|
|
MP 2.017 |
Medicine |
Active |
|
|
MP 2.391 |
Medicine |
Active |
|
|
MP 4.029 |
Other Treatments |
Active |
|
|
MP 2.386 |
Medicine |
Active |
|
|
MP 4.002 |
Other Treatments |
Active |
|
|
MP 6.007 |
Medicine |
External Infusion Pumps for Insulin Delivery and Artificial Pancreas Device |
Active |
|
MP 2.068 |
Medicine |
Active |
|
|
MP 2.034 |
Medicine |
Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions |
Active |
|
MP 5.049 |
Radiology/Imaging |
Active |
|
|
MP 2.018 |
Medicine |
Active |
|
|
MP 6.028 |
Durable Medical Equipment |
Active |
|
|
MP 2.378 |
Medicine |
Active |
|
|
MP 6.031 |
Durable Medical Equipment |
Gas Permeable Scleral Contact Lens and Therapeutic Soft Contact Lens |
Active |
|
MP 2.069 |
Medicine |
Active |
|
|
MP 1.144 |
Surgery |
Active |
|
|
MP 2.245 |
Medicine |
Active |
|
|
MP 2.315 |
Medicine |
Active |
|
|
MP 2.280 |
Medicine |
Active |
|
|
MP 2.396 |
Medicine |
Active |
|
|
MP 2.360 |
Medicine |
Active |
|
|
MP 2.313 |
Medicine |
Gene Expression Testing in Patients with Stable Ischemic Heart Disease |
Active |
|
MP 2.323 |
Medicine |
General Approach to Evaluating the Utility of Genetic Panels |
Active |
|
MP 2.326 |
Medicine |
Active |
|
|
MP 2.325 |
Medicine |
Genetic Cancer Susceptibility Panels Using Next Generational Sequencing |
Active |
|
MP 2.320 |
Medicine |
Active |
|
|
MP 2.251 |
Medicine |
Active |
|
|
MP 2.050 |
Medicine |
Active |
|
|
MP 2.322 |
Medicine |
Active |
|
|
MP 2.233 |
Medicine |
Active |
|
|
MP 2.242 |
Medicine |
Active |
|
|
MP 2.242 |
Medicine |
Active |
|
|
MP 2.264 |
Medicine |
Genetic Testing for Diagnosis and Management of Mental Health Conditions |
Active |
|
MP 2.257 |
Medicine |
Active |
|
|
MP 2.262 |
Medicine |
Active |
|
|
MP 2.357 |
Medicine |
Genetic Testing for FLT3, NPM1 and CEBPA Variants in Cytogenetically Normal Acute Myeloid Leukemia |
Active |
|
MP 2.321 |
Medicine |
Active |
|
|
MP 2.246 |
Medicine |
Active |
|
|
MP 2.362 |
Medicine |
Active |
|
|
MP 2.308 |
Medicine |
Active |
|
|
MP 2.319 |
Medicine |
Active |
|
|
MP 2.312 |
Medicine |
Active |
|
|
MP 2.318 |
Medicine |
Active |
|
|
MP 2.363 |
Medicine |
Genetic Testing for Heterozygous Familial Hypercholesterolemia |
Active |
|
MP 2.328 |
Medicine |
Active |
|
|
MP 2.253 |
Medicine |
Active |
|
|
MP 2.274 |
Medicine |
Active |
|
|
MP 2.274 |
Medicine |
Active |
|
|
MP 2.310 |
Medicine |
Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment |
Active |
|
MP 5.013 |
Radiology/Imaging |
Genetic Testing for Lynch Syndrome and Inherited Colon Cancer Syndromes |
Active |
|
MP 2.260 |
Medicine |
Active |
|
|
MP 2.331 |
Medicine |
Active |
|
|
MP 2.273 |
Medicine |
Active |
|
|
MP 2.358 |
Medicine |
Active |
|
|
MP 2.255 |
Medicine |
Active |
|
|
MP 2.276 |
Medicine |
Genetic Testing for Pathogenic FMR1 Variants (Including Fragile X Syndrome) |
Active |
|
MP 2.248 |
Medicine |
Genetic Testing for Predisposition to Inherited Hypertrophic Cardiomyopathy |
Active |
|
MP 2.355 |
Medicine |
Genetic Testing for the Diagnosis of Inherited Peripheral Neuropathies |
Active |
|
MP 2.247 |
Medicine |
Active |
|
|
MP 2.307 |
Medicine |
Active |
|
|
MP 2.306 |
Medicine |
Active |
|
|
MP 2.311 |
Medicine |
Active |
|
|
MP 2.393 |
Medicine |
Active |
|
|
MP 2.395 |
Medicine |
Active |
|
|
MP 2.394 |
Medicine |
Active |
|
|
MP 2.279 |
Medicine |
Germline Genetic Testing for Gene Variants Associated with Breast Cancer in Individuals at High |
Active |
|
MP 2.211 |
Medicine |
Active |
|
|
MP 2.384 |
Medicine |
Germline Genetic Testing for Hereditary Diffuse Gastric Cancer (CDH1,CTNNA1) |
Active |
|
MP 2.392 |
Medicine |
Germline Genetic Testing for Pancreatic Cancer Susceptibility Genes |
Active |
|
MP 6.049 |
Durable Medical Equipment |
Active |
|
|
MP 5.055 |
Radiology/Imaging |
Active |
|
|
MP 9.007 |
Transplant |
Active |
|
|
MP 9.014 |
Transplant |
Active |
|
|
MP 9.041 |
Transplant |
Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia |
Active |
|
MP 9.040 |
Transplant |
Hematopoietic Cell Transplantation for Acute Myeloid Leukemia |
Active |
|
MP 9.053 |
Transplant |
Active |
|
|
MP 9.050 |
Transplant |
Hematopoietic Cell Transplantation for CNS Embryonal Tumors, CNS Germ Cell Tumors and Ependymoma |
Active |
|
MP 9.038 |
Transplant |
Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma |
Active |
|
MP 9.039 |
Transplant |
Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia |
Active |
|
MP 9.047 |
Transplant |
Hematopoietic Cell Transplantation for Epithelial Ovarian Cancer |
Active |
|
MP 9.043 |
Transplant |
Active |
|
|
MP 9.048 |
Transplant |
Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults |
Active |
|
MP 9.042 |
Transplant |
Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas |
Active |
|
MP 9.044 |
Transplant |
Active |
|
|
MP 9.045 |
Transplant |
Active |
|
|
MP 9.054 |
Transplant |
Hematopoietic Cell Transplantation for Solid Tumors of Childhood |
Active |
|
MP 9.046 |
Transplant |
Hematopoietic Cell Transplantation for Waldenstrom Macroglobulinemia |
Active |
|
MP 9.052 |
Transplant |
Hematopoietic Cell Transplantation in the Treatment of Germ-Cell Tumors |
Active |
|
MP 6.001 |
Durable Medical Equipment |
Hospital Beds, Accessories, and Pressure-Reducing Support Surfaces |
Active |
|
MP 2.070 |
Medicine |
Hyperbaric Oxygen Therapy (HBO) (Formerly Hyperbaric Oxygen Pressurization) |
Active |
|
MP 2.021 |
Medicine |
Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies |
Active |
|
MP 1.019 |
Surgery |
Implantable Bone-Conduction and Bone-Anchored Hearing Prosthetic Devices |
Active |
|
MP 1.058 |
Surgery |
Active |
|
|
MP 1.044 |
Surgery |
Active |
|
|
MP 4.012 |
Other Treatments |
Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence |
Active |
|
MP 3.019 |
Ancillary Services |
Active |
|
|
MP 2.079 |
Medicine |
Active |
|
|
MP 6.047 |
Durable Medical Equipment |
Active |
|
|
MP 1.120 |
Surgery |
Active |
|
|
MP 6.058 |
Durable Medical Equipment |
Intraocular Lenses, Spectacle Correction,and Iris Prosthesis |
Active |
|
MP 2.389 |
Medicine |
Intraocular Radiotherapy for Age-Related Macular Degeneration |
Active |
|
MP 2.030 |
Medicine |
Active |
|
|
MP 2.167 |
Medicine |
Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders |
Active |
|
MP 2.026 |
Medicine |
Active |
|
|
MP 4.005 |
Other Treatments |
Active |
|
|
MP 2.159 |
Medicine |
Active |
|
|
MP 2.278 |
Medicine |
Active |
|
|
MP 2.277 |
Medicine |
Active |
|
|
MP 8.001 |
Therapy |
Investigational Physical Medicine And Specialized Physical Medicine Interventions (Outpatient) |
Active |
|
MP 1.162 |
Surgery |
Irreversible Electroporation of Tumors Located in the Liver, Pancreas, Kidney or Lung |
Active |
|
MP 9.012 |
Transplant |
Active |
|
|
MP 9.013 |
Transplant |
Isolated Small Bowel Transplant and Small Bowel/Liver and Multivisceral Transplant |
Active |
|
MP 2.281 |
Medicine |
JAK2, MPL, and CLR Mutation Analysis in Myeloproliferative Neoplasms |
Active |
|
MP 2.309 |
Medicine |
KIF6 Genotyping for Predicting Cardiovascular Risk and/or Effectiveness of Statin Therapy |
Active |
|
MP 2.316 |
Medicine |
KRAS, NRAS, and BRAF Variant Analysis in Metastatic Colorectal Cancer |
Active |
|
MP 9.005 |
Transplant |
Kidney Transplants, Pancreas Transplants, and Simultaneous Kidney/Pancreas Transplant |
Active |
|
MP 6.012 |
Durable Medical Equipment |
Active |
|
|
MP 2.354 |
Medicine |
Laboratory and Genetic Testing for Use of 5-Flourouracil in Patients with Cancer |
Active |
|
MP 7.027 |
OBGYN/Reproduction |
Laparoscopic and Percutaneous Techniques for the Myolysis of Uterine Fibroids |
Active |
|
MP 4.047 |
Other Treatments |
Laser Treatment for Vulvovaginal Atrophy and Vaginal Rejuvenation |
Active |
|
MP 1.008 |
Surgery |
Active |
|
|
MP 2.046 |
Medicine |
Active |
|
|
MP 9.006 |
Transplant |
Active |
|
|
MP 6.021 |
Durable Medical Equipment |
Active |
|
|
MP 1.097 |
Surgery |
Active |
|
|
MP 6.042 |
Durable Medical Equipment |
Active |
|
|
MP 9.015 |
Transplant |
Active |
|
|
MP 6.027 |
Durable Medical Equipment |
Active |
|
|
MP 1.145 |
Surgery |
Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux Disease |
Active |
|
MP 5.053 |
Radiology/Imaging |
Active |
|
|
MP 5.011 |
Radiology/Imaging |
Active |
|
|
MP 5.008 |
Radiology/Imaging |
Mammography (Including Computer Aided Detection Mammography and Positron Emission Mammography) |
Active |
|
MP 6.059 |
Durable Medical Equipment |
Active |
|
|
MP 4.038 |
Other Treatments |
Active |
|
|
MP 6.022 |
Durable Medical Equipment |
Active |
|
|
MP 6.039 |
Durable Medical Equipment |
Mechanical Stretching Devices for Contracture and Joint Stiffness |
Active |
|
MP 6.064 |
Durable Medical Equipment |
Active |
|
|
MP 4.003 |
Other Treatments |
Active |
|
|
MP 2.304 |
Medicine |
Active |
|
|
MP 2.090 |
Medicine |
Active |
|
|
MP 2.275 |
Medicine |
Minimally Invasive Ablation Procedures for Morton and Other Peripheral Neuromas |
Active |
|
MP 2.275 |
Medicine |
Active |
|
|
MP 2.259 |
Medicine |
Molecular Panel Testing of Cancers to Identify Targeted Therapies |
Active |
|
MP 2.377 |
Medicine |
Molecular Testing for Germline Variants Associated with Ovarian Cancer (BRIP1, RAD51C, RAD51D, NBN) |
Active |
|
MP 2.266 |
Medicine |
Molecular Testing for The Management of Pancreatic Cysts and Solid Pancreaticobiliary Lesions |
Active |
|
MP 2.375 |
Medicine |
Active |
|
|
MP 2.231 |
Medicine |
Active |
|
|
MP 2.387 |
Medicine |
Active |
|
|
MP 2.315 |
Medicine |
Multigene Expression Assay for Predicting Recurrence in Colon Cancer |
Active |
|
MP 2.270 |
Medicine |
Active |
|
|
MP 5.054 |
Radiology/Imaging |
Myocardial Sympathetic Innervation Imaging in Patients with Heart Failure |
Active |
|
MP 2.094 |
Medicine |
Active |
|
|
MP 4.004 |
Other Treatments |
Active |
|
|
MP 8.012 |
Therapy |
Active |
|
|
MP 6.051 |
Durable Medical Equipment |
Neuromuscular and Functional Neuromuscular Electrical Stimulation |
Active |
|
MP 2.379 |
Medicine |
Next-Generation Sequencing For The Assessment of Measurable Residual Disease |
Active |
|
MP 3.009 |
Ancillary Services |
Active |
|
|
MP 7.026 |
OBGYN/Reproduction |
Active |
|
|
MP 2.261 |
Medicine |
Active |
|
|
MP 2.256 |
Medicine |
Noninvasive Prenatal Screening for Fetal Aneuploidies and Microdeletions Using Cell Free DNA |
Active |
|
MP 2.252 |
Medicine |
Noninvasive Techniques for the Evaluation and Monitoring of Patients with Chronic Liver Disease |
Active |
|
MP 2.071 |
Medicine |
Active |
|
|
MP 2.372 |
Medicine |
Active |
|
|
MP 2.103 |
Medicine |
Active |
|
|
MP 4.019 |
Other Treatments |
Oncological Applications of Photodynamic Therapy including Barrett's Esophagus |
Active |
|
MP 2.083 |
Medicine |
Active |
|
|
MP 2.056 |
Medicine |
Ophthalmologic Techniques That Evaluate the Posterior Eye Segment |
Active |
|
MP 2.085 |
Medicine |
Optical Coherence Tomography (OCT) of the Anterior Eye Segment |
Active |
|
MP 2.066 |
Medicine |
Optical Diagnostic Devices for Evaluation of Skin Lesions Suspected of Malignancy |
Active |
|
MP 2.383 |
Medicine |
Active |
|
|
MP 1.101 |
Surgery |
Active |
|
|
MP 4.039 |
Other Treatments |
Active |
|
|
MP 2.080 |
Medicine |
Active |
|
|
MP 2.005 |
Medicine |
Active |
|
|
MP 2.092 |
Medicine |
PENFS, CES, Auricular Electrostimulation, and External Trigeminal Nerve Stimulation |
Active |
|
MP 2.097 |
Medicine |
Paraspinal Surface Electromyography to Evaluate and Monitor Back Pain |
Active |
|
MP 6.024 |
Durable Medical Equipment |
Pelvic Floor Stimulation as a Treatment of Urinary and Fecal Incontinence |
Active |
|
MP 2.397 |
Medicine |
Percutaneous Electrical Nerve Field Stimulation for Irritable Bowel Syndrome |
Active |
|
MP 6.050 |
Durable Medical Equipment |
Percutaneous Electrical Nerve Stimulation (PENs) and Percutaneous Neuromodulation Therapy (PNT) |
Active |
|
MP 1.124 |
Surgery |
Active |
|
|
MP 1.134 |
Surgery |
Active |
|
|
MP 1.141 |
Surgery |
Active |
|
|
MP 1.109 |
Surgery |
Periureteral Bulking Agents as Treatment of Vesicoureteral Reflux |
Active |
|
MP 1.143 |
Surgery |
Peroral Endoscopic Myotomy (POEM) for Treatment of Esophageal Achalasia |
Active |
|
MP 2.218 |
Medicine |
Pharmacogenomic and Metabolite Markers for Patients Treated with Thiopurines |
Active |
|
MP 4.008 |
Other Treatments |
Active |
|
|
MP 9.001 |
Transplant |
Active |
|
|
MP 4.031 |
Other Treatments |
Active |
|
|
MP 2.335 |
Medicine |
Active |
|
|
MP 5.008 |
Radiology/Imaging |
Active |
|
|
MP 6.053 |
Durable Medical Equipment |
Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis |
Active |
|
MP 6.037 |
Durable Medical Equipment |
Power Wheelchairs, Power Operated Vehicles (POV) and Related Options and Accessories |
Active |
|
MP 7.009 |
OBGYN/Reproduction |
Active |
|
|
MP 3.004 |
Ancillary Services |
Active |
|
|
MP 2.053 |
Medicine |
Active |
|
|
MP 2.061 |
Medicine |
Active |
|
|
MP 1.147 |
Surgery |
Active |
|
|
MP 2.343 |
Medicine |
Active |
|
|
MP 2.337 |
Medicine |
Proteomic Testing for Targeted Therapy in Non-Small-Cell Lung Cancer |
Active |
|
MP 1.084 |
Surgery |
Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors |
Active |
|
MP 1.055 |
Surgery |
Radiofrequency Ablation of Primary or Metastatic Liver Tumors |
Active |
|
MP 2.033 |
Medicine |
Active |
|
|
MP 1.103 |
Surgery |
Active |
|
|
MP 1.013 |
Surgery |
Active |
|
|
MP 1.156 |
Surgery |
Responsive Neurostimulation for the Treatment of Refractory Focal Epilepsy |
Active |
|
MP 2.088 |
Medicine |
Active |
|
|
MP 1.033 |
Surgery |
Active |
|
|
MP 5.021 |
Radiology/Imaging |
Scintimammography and Gamma Imaging of the Breast and Axilla |
Active |
|
MP 2.176 |
Medicine |
Active |
|
|
MP 1.130 |
Surgery |
Semi-Implantable and Fully Implantable Middle Ear Hearing Aid |
Active |
|
MP 8.011 |
Therapy |
Sensory Integration Therapy and Auditory Integration Therapy |
Active |
|
MP 2.222 |
Medicine |
Serum Antibody Markers for Diagnosing Inflammatory Bowel Disease |
Active |
|
MP 2.269 |
Medicine |
Active |
|
|
MP 1.094 |
Surgery |
Active |
|
|
MP 2.241 |
Medicine |
Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Therapy in Non-Small Cell Lung |
Active |
|
MP 2.316 |
Medicine |
Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Metastatic Colorec |
Active |
|
MP 2.388 |
Medicine |
Somatic Biomarker Testing For Immune Checkpoint Inhibitor Therapy (MSIMMR, PD-L1, TMB) |
Active |
|
MP 2.316 |
Medicine |
Active |
|
|
MP 2.364 |
Medicine |
Active |
|
|
MP 8.002 |
Therapy |
Active |
|
|
MP 4.046 |
Other Treatments |
Active |
|
|
MP 1.069 |
Surgery |
Active |
|
|
MP 6.063 |
Durable Medical Equipment |
Active |
|
|
MP 2.089 |
Medicine |
Active |
|
|
MP 2.373 |
Medicine |
Active |
|
|
MP 1.140 |
Surgery |
Active |
|
|
MP 2.345 |
Medicine |
Active |
|
|
MP 1.114 |
Surgery |
Active |
|
|
MP 1.163 |
Surgery |
Active |
|
|
MP 1.129 |
Surgery |
Active |
|
|
MP 1.082 |
Surgery |
Active |
|
|
MP 1.128 |
Surgery |
Active |
|
|
MP 1.161 |
Surgery |
Active |
|
|
MP 2.053 |
Medicine |
Active |
|
|
MP 6.045 |
Durable Medical Equipment |
Active |
|
|
MP 1.160 |
Surgery |
Synthetic Cartilage Implants for the First Metatarsophalangeal Joint |
Active |
|
MP 2.066 |
Medicine |
Technologies for the Evaluation of Skin Lesions Suspected of Malignancy |
Active |
|
MP 1.164 |
Surgery |
Temporarily Implanted Nitinol Device (iTind) for Benign Prostatic Hyperplasia |
Active |
|
MP 2.062 |
Medicine |
Active |
|
|
MP 6.061 |
Durable Medical Equipment |
Active |
|
|
MP 1.086 |
Surgery |
Active |
|
|
MP 5.017 |
Radiology/Imaging |
Active |
|
|
MP 6.046 |
Durable Medical Equipment |
Threshold Electrical Stimulation as a Treatment of Motor Disorders |
Active |
|
MP 1.134 |
Surgery |
Active |
|
|
MP 1.026 |
Surgery |
Total Artificial Hearts and Implantable Ventricular Assist Devices |
Active |
|
MP 6.020 |
Durable Medical Equipment |
Transcutaneous Electrical Nerve Stimulation and Transcutaneous Afferent Patterned Stimulation |
Active |
|
MP 2.053 |
Medicine |
Active |
|
|
MP 1.057 |
Surgery |
Active |
|
|
MP 4.034 |
Other Treatments |
Transvaginal and Transurethral Radiofrequency Tissue Remodeling for Urinary Stress Incontinence |
Active |
|
MP 1.061 |
Surgery |
Active |
|
|
MP 1.061 |
Surgery |
Active |
|
|
MP 2.072 |
Medicine |
Active |
|
|
MP 6.054 |
Durable Medical Equipment |
Active |
|
|
MP 6.021 |
Durable Medical Equipment |
Active |
|
|
MP 6.052 |
Durable Medical Equipment |
Active |
|
|
MP 2.249 |
Medicine |
Active |
|
|
MP 1.034 |
Surgery |
Active |
|
|
MP 1.146 |
Surgery |
Active |
|
|
MP 2.065 |
Medicine |
Active |
|
|
MP 5.046 |
Radiology/Imaging |
Active |
|
|
MP 1.136 |
Surgery |
Active |
|
|
MP 4.007 |
Other Treatments |
Active |
|
|
MP 5.037 |
Radiology/Imaging |
Whole Body Dual X-Ray Absorptiometry to Determine Body Composition |
Active |
|
MP 2.324 |
Medicine |
Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders |
Active |
|
MP 5.033 |
Radiology/Imaging |
Wireless Capsule Endoscopy for Gastrointestinal (GI) Disorders |
Active |
|
MP 4.028 |
Other Treatments |
Active |
|
|
IC-0610NC |
Retired |
||
|
MP 2.036 |
Medicine |
Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry (Retired 4/1/2025) |
Retired |
|
Retired |
|||
|
MP 2.359 |
Medicine |
Analysis of MGMT Promoter Methylation in Malignant Gliomas (Retired 1/1/2024) |
Retired |
|
IC-0356 |
Retired |
||
|
MP 1.002 |
Surgery |
Retired |
|
|
MP 2.099 |
Medicine |
Automated Point of Care Nerve Conduction Tests (Retired 1/1/2025) |
Retired |
|
MP 2.100 |
Medicine |
Retired |
|
|
MP 1.017 |
Surgery |
Bio-Engineered Skin and Soft Tissue Substitutes (Retired 4/1/2024) |
Retired |
|
IC-0561 |
Retired |
||
|
MP 2.370 |
Medicine |
Retired |
|
|
MP 1.122 |
Surgery |
Retired |
|
|
MP 2.271 |
Medicine |
Retired |
|
|
MP 2.007 |
Medicine |
Cardiac Intervention Therapy for the Treatment of Heart Failure (Retired 4/1/2025) |
Retired |
|
MP 8.005 |
Therapy |
Cardiac Rehabilitation In The Outpatient Setting (Retired 9/1/2025) |
Retired |
|
MP 1.081 |
Surgery |
Cardioverter Defibrillators (Implantable and External) (Retired 4/1/2025) |
Retired |
|
MP 8.007 |
Therapy |
Retired |
|
|
MP 1.106 |
Surgery |
Computer Assisted Navigation for Orthopedic Procedures (retired 9/1/2024) |
Retired |
|
MP 4.048 |
Other Treatments |
Retired |
|
|
MP 2.380 |
Medicine |
Diagnosis and Treatment of Post Acute COVID (PASC) (Retired 8/1/2025) |
Retired |
|
MP 3.016 |
Ancillary Services |
Retired |
|
|
MP 6.048 |
Durable Medical Equipment |
Retired |
|
|
MP 2.032 |
Medicine |
Retired |
|
|
MP 1.149 |
Surgery |
Endovascular Therapies for Extracranial Vertebral Artery Disease (Retired 4/1/2025) |
Retired |
|
MP 2.014 |
Medicine |
Retired |
|
|
IC-0357 |
Epoetin alfa: Epogen®; Procrit®; Retacrit® (Retired 11/1/2023) |
Retired |
|
|
MP 2.016 |
Medicine |
Retired |
|
|
Retired |
|||
|
MP 2.369 |
Medicine |
Retired |
|
|
MP 1.152 |
Surgery |
Functional Endoscopic Sinus Surgery for Chronic Rhinosinusitis (Retired 7/1/2025) |
Retired |
|
AHS M2058 |
Genetic Testing for Adolescent Idiopathic Scoliosis (Retired 10/1/2023) |
Retired |
|
|
MP 2.361 |
Medicine |
Genetic Testing for Statin-Induced Myopathy (Retired 5/1/2025) |
Retired |
|
MP 2.279 |
Medicine |
Retired |
|
|
Retired |
|||
|
MP 7.019 |
OBGYN/Reproduction |
Retired |
|
|
MP 5.047 |
Radiology/Imaging |
Retired |
|
|
MP 1.151 |
Surgery |
Retired |
|
|
MP 4.013 |
Other Treatments |
Retired |
|
|
MP 2.146 |
Medicine |
Retired |
|
|
MP 1.127 |
Surgery |
Retired |
|
|
MP 4.024 |
Other Treatments |
Retired |
|
|
MP 8.006 |
Therapy |
Retired |
|
|
MP 2.329 |
Medicine |
Measurement of Serum Antibodies to Selected Biologic Agents (Retired 7/1/2023) |
Retired |
|
MP 2.303 |
Medicine |
Retired |
|
|
IC-0359 |
Retired |
||
|
MP 2.377 |
Medicine |
Retired |
|
|
MP 2.231 |
Medicine |
Retired |
|
|
MP 2.330 |
Medicine |
Multi-Biomarker Disease Activity Blood Test for Rheumatoid Arthritis (Retired 10/1/2023) |
Retired |
|
MP 5.054 |
Radiology/Imaging |
Myocardial Sympathetic Innervation Imaging in Patients with Heart Failure (Retired 6/1/2024) |
Retired |
|
MP 4.027 |
Other Treatments |
Neuropsychological Testing for Medical Purposes (Retired 7/1/2025) |
Retired |
|
MP 2.256 |
Medicine |
Retired |
|
|
MP 8.004 |
Therapy |
Retired |
|
|
MP 3.015 |
Ancillary Services |
Office Based Procedures Performed in a Facility (Retired 10/1/2023) |
Retired |
|
MP 2.385 |
Medicine |
Retired |
|
|
MP 8.008 |
Therapy |
Retired |
|
|
MP 1.116 |
Surgery |
Retired |
|
|
IC-0595 |
Retired |
||
|
MP 3.004 |
Ancillary Services |
Retired |
|
|
MP 1.154 |
Surgery |
Retired |
|
|
MP 4.009 |
Other Treatments |
Procedures of Questionable Current Usefulness (Retired 6/1/2025) |
Retired |
|
MP 6.018 |
Durable Medical Equipment |
Retired |
|
|
MP 2.095 |
Medicine |
Retired |
|
|
MP 5.022 |
Radiology/Imaging |
Retired |
|
|
MP 4.049 |
Other Treatments |
Retired |
|
|
MP 6.060 |
Durable Medical Equipment |
Retired |
|
|
MP 2.086 |
Medicine |
Retinal Telescreening for Diabetic Retinopathy (Retired 1/1/2026) |
Retired |
|
MP 6.032 |
Durable Medical Equipment |
Retired |
|
|
MP 4.032 |
Other Treatments |
Suprachoroidal Delivery of Pharmacologic Agents (Effective 2/1/2024) |
Retired |
|
MP 2.057 |
Medicine |
Retired |
|
|
MP 4.044 |
Other Treatments |
Retired |
|
|
AHS – M2141 |
Testing of Homocysteine Metabolism-Related Conditions (Retired 5/1/2023) |
Retired |
|
|
MP 1.135 |
Surgery |
Transcatheter Aortic Valve Implantation for Aortic Stenosis (Retired 4/1/2025) |
Retired |
|
MP 1.153 |
Surgery |
Retired |
|
|
MP 1.139 |
Surgery |
Transcatheter Pulmonary Valve Implantation (Retired 4/1/2025) |
Retired |
|
MP 2.382 |
Medicine |
Treatment for Duchenne Muscular Dystrophy (Retired 1/1/2025) |
Retired |
|
MP 1.095 |
Surgery |
Treatment of Menieres and Sudden Hearing Loss (Retired 8/1/2025) |
Retired |
|
MP 2.038 |
Medicine |
Retired |
|
|
MP 2.078 |
Medicine |
Ultrafiltration in Decompensated Heart Failure (Retired 4/1/2025) |
Retired |
|
MP 5.036 |
Radiology/Imaging |
Retired |
|
|
Retired |
|||
|
AHS – G2133 |
Retired |
||
|
MP 2.143 |
Medicine |
Retired |
|
|
MP 2.010 |
Medicine |
Retired |
|
|
MP 3.008 |
Ancillary Services |
Retired |
|
|
MP 2.371 |
Medicine |
Therapeutic Radiopharmaceuticals for Neuroendocrine Tumors (Retired 2/1/2026) |
Retired |
|
MP 2.208 |
Medicine |
Retired |